Anna Maria Frustaci (Annamaria Frustaci, Anna M Frustaci)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Hematological oncology

Cancers

Blood advances

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Enrica Antonia Martino, Francesca Romana Mauro, Gianluigi Reda, Luca Laurenti, Andrea Visentin, Anna Maria Frustaci, Ernesto Vigna, Sara Pepe, Gioacchino Catania, Giacomo Loseto, Roberta Murru, Annalisa Chiarenza, Paolo Sportoletti, Maria Ilaria Del Principe, Roberta Laureana, Marta Coscia, Sara Galimberti, Eleonora Ferretti, Antonella Zucchetto, Riccardo Bomben, Jerry Polesel, Alessandra Tedeschi, Davide Rossi, Francesco Angotzi, Antonino Neri, Fortunato Morabito, Valter Gattei, Massimo Gentile
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort. Hematological oncology 42 (1) (2024)
Enrica Antonia Martino, Francesca Romana Mauro, Gianluigi Reda, Luca Laurenti, Andrea Visentin, Anna Maria Frustaci, Ernesto Vigna, Sara Pepe, Gioacchino Catania, Giacomo Loseto, Roberta Murru, Annalisa Chiarenza, Paolo Sportoletti, Maria Ilaria Del Principe, Roberta Laureana, Marta Coscia, Sara Galimberti, Eleonora Ferretti, Antonella Zucchetto, Riccardo Bomben, Jerry Polesel, Alessandra Tedeschi, Davide Rossi, Francesco Angotzi, Antonino Neri, Fortunato Morabito, Valter Gattei, Massimo Gentile
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort. Hematological oncology 42 (1) (2024)
Luca Laurenti, Lydia Scarfò, Anna Maria Frustaci, Alessandro Sanna, Emilia Iannella, Morena Caira, Paola Finsinger, Silvia Schifano, Benedetta Neri, Stefano Molica, Francesca Romana Mauro
Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience. Hematological oncology (2023)
Luca Laurenti, Lydia Scarfò, Anna Maria Frustaci, Alessandro Sanna, Emilia Iannella, Morena Caira, Paola Finsinger, Silvia Schifano, Benedetta Neri, Stefano Molica, Francesca Romana Mauro
Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience. Hematological oncology (2023)
Anna Maria Frustaci, Marina Deodato, Giulia Zamprogna, Roberto Cairoli, Marco Montillo, Alessandra Tedeschi
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities. Cancers 15 (5) (2023)
Ilaria Del Giudice, Luca Vincenzo Cappelli, Julio Delgado, Carsten Utoft Niemann, Michael Asger Andersen, Emelie Hamotal Curovic Rotbain, Kathrine Aarup, Renata Walewska, Andrea Visentin, Marina Deodato, Anna Maria Frustaci, Chiara Cavalloni, Massimo Gentile, Mohamad A Yassin, Deepesh P Lad, Lydia Scarfò, Max Flogegard, Mattias Mattsson, Sara Raponi, Caterina Ilari, Irene Della Starza, Ester M Orlandi, Alessandra Tedeschi, Livio Trentin, Gianpietro Semenzato, Anna Guarini, Paolo Ghia, Emili Montserrat, Robin Foà
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature. British journal of haematology (2023)
Anna Maria Frustaci, Marina Deodato, Giulia Zamprogna, Roberto Cairoli, Marco Montillo, Alessandra Tedeschi
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities. Cancers 15 (5) (2023)
Francesca Romana Mauro, Diana Giannarelli, Clementina M Galluzzo, Andrea Visentin, Anna Maria Frustaci, Paolo Sportoletti, Candida Vitale, Gianluigi Reda, Massimo Gentile, Luciano Levato, Roberta Murru, Daniele Armiento, Maria C Molinari, Giulia Proietti, Sara Pepe, Filomena De Falco, Veronica Mattiello, Luca Barabino, Roberta Amici, Marta Coscia, Alessandra Tedeschi, Corrado Girmenia, Livio Trentin, Silvia Baroncelli
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study. Cancers 15 (11) (2023)
Silvia Bonfiglio, Lesley-Ann Sutton, Viktor Ljungström, Antonella Capasso, Tatjana Pandzic, Simone Weström, Hassan Foroughi-Asl, Aron Skaftason, Anna Gellerbring, Anna Lyander, Francesca Gandini, Gianluca Gaidano, Livio Trentin, Lisa Bonello, Gianluigi Reda, Csaba Bödör, Niki Stavroyianni, Constantine S Tam, Roberto Marasca, Francesco Forconi, Panayiotis Panayiotidis, Ingo Ringshausen, Ozren Jaksic, Anna Maria Frustaci, Sunil Iyengar, Marta Coscia, Stephen P Mulligan, Loïc Ysebaert, Vladimir Strugov, Carolina Pavlovsky, Renata Walewska, Anders Österborg, Diego Cortese, Pamela Ranghetti, Panagiotis Baliakas, Kostas Stamatopoulos, Lydia Scarfò, Richard Rosenquist, Paolo Ghia
BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib. Blood advances (2023)
Lydia Scarfò, Silvia Ferrari, Anna Maria Frustaci, Monica Tani, Alessia Bari, Eloise Scarano, Maria Colia, Pamela Ranghetti, Piera Angelillo, Paola Ronchi, Maurilio Ponzoni, Andrés José Maria Ferreri, Paolo Ghia
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial. Blood advances 6 (18) (2022)
Anna Maria Frustaci, Giovanni Del Poeta, Andrea Visentin, Paolo Sportoletti, Alberto Fresa, Candida Vitale, Roberta Murru, Annalisa Chiarenza, Alessandro Sanna, Francesca Romana Mauro, Gianluigi Reda, Massimo Gentile, Marzia Varettoni, Claudia Baratè, Chiara Borella, Antonino Greco, Marina Deodato, Giulia Zamprogna, Roberta Laureana, Alessandra Cipiciani, Andrea Galitzia, Angelo Curto Pelle, Francesca Morelli, Lucio Malvisi, Marta Coscia, Luca Laurenti, Livio Trentin, Marco Montillo, Roberto Cairoli, Alessandra Tedeschi
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia. Therapeutic advances in hematology 13 (2022)
Gabriela Forestieri, Lodovico Terzi di Bergamo, Marina Deodato, Anna Maria Frustaci, Riccardo Moia, Clara Deambrogi, Silvia Rasi, Francesco Autore, Michele Merli, Roberta Mattarucchi, Gaby Fahrni, Lydia Scarfo', Daniela Gussetti, Pietro Bulian, Annagiulia Zanatta, Valeria Spina, Alessio Bruscaggin, Katia Pini, Deborah Piffaretti, Maria Cristina Pirosa, Matin Salehi, Joyce Marques de Almeida, Jakob Passweg, Franco Cavalli, Emanuele Zucca, Bernhard Gerber, Georg Stussi, Valter Gattei, Paolo Ghia, Michael Gregor, Francesco Passamonti, Luca Laurenti, Gianluca Gaidano, Alessandra Tedeschi, Davide Rossi, Adalgisa Condoluci
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia. Hematological oncology (2022)
Gianluigi Reda, Veronica Mattiello, Anna Maria Frustaci, Andrea Visentin, Francesca Romana Mauro, Idanna Innocenti, Massimo Gentile, Diana Giannarelli, Alessandro Noto, Ramona Cassin, Antonino Neri, Luca Laurenti, Alessandra Tedeschi
Ibrutinib in patients over 80 with chronic lymphocytic leukemia: a multicenter Italian cohort. Blood advances (2022)
Stefano Molica, Diana Giannarelli, Andrea Visentin, Gianluigi Reda, Paolo Sportoletti, Anna Maria Frustaci, Annalisa Chiarenza, Stefania Ciolli, Candida Vitale, Luca Laurenti, Lorenzo De Paoli, Roberta Murru, Massimo Gentile, Riccardo Moia, Gian Matteo Rigolin, Luciano Levato, Annamaria Giordano, Giovanni Del Poeta, Caterina Stelitano, Marina Deodato, Claudia Ielo, Alessandro Noto, Valerio Guarente, Marta Coscia, Alessandra Tedeschi, Gianluca Gaidano, Antonio Cuneo, Robin Foa', Livio Trentin, Francesca Romana Mauro
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model. American journal of hematology 97 (5) (2022)
Riccardo Moia, Riccardo Dondolin, Maria Stefania De Propris, Donatella Talotta, Samir Mouhssine, Francesca Perutelli, Gianluigi Reda, Veronica Mattiello, Gian Matteo Rigolin, Marina Motta, Jacopo Olivieri, Renato Fanin, Omar Perbellini, Isacco Ferrarini, Francesca Romana Mauro, Ilaria Del Giudice, Luca Laurenti, Annamaria Tomasso, Massimo Gentile, Anna Maria Frustaci, Alessandra Tedeschi, Alessandro Gozzetti, Caterina Stelitano, Chiara Rusconi, Carol Moreno, Francesco Forconi, Roberto Marasca, Marta Coscia, Davide Rossi, Robin Foà, Gianluca Gaidano
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. Hematological oncology (2022)
Anna Maria Frustaci, Maria L Pioltelli, Emanuele Ravano, Federica Di Ruscio, Daniela A Campisi, Massimo Puoti, Roberto Cairoli
Intrahospital COVID-19 infection outbreak management: Keep calm and carry on. Hematological oncology 39 (3) (2021)
Anna Maria Frustaci, Michele Nichelatti, Marina Deodato, Giulia Zamprogna, Periana Minga, Maria Luisa Pioltelli, Roberto Cairoli, Alessandra Tedeschi
Health-related quality of life in Waldenstrom Macroglobulinemia and IgM-related disorders: A single institution experience. Hematological oncology 38 (1) (2019)

Anna Maria Frustaci.css-eqlu8i{font-size:small;padding-left:4px;} (Annamaria Frustaci, Anna M Frustaci)

Publication Activity (10 Years)

Top Topics

Top Venues

Anna Maria Frustaci (Annamaria Frustaci, Anna M Frustaci)